Ontology highlight
ABSTRACT:
SUBMITTER: Park E
PROVIDER: S-EPMC3162353 | biostudies-literature | 2011 Aug
REPOSITORIES: biostudies-literature
Blood 20110628 8
Relapse of drug-resistant acute lymphoblastic leukemia (ALL) has been associated with increased expression of survivin/BIRC5, an inhibitor of apoptosis protein, suggesting a survival advantage for ALL cells. In the present study, we report that inhibition of survivin in patient-derived ALL can eradicate leukemia. Targeting survivin with shRNA in combination with chemotherapy resulted in no detectable minimal residual disease in a xenograft model of primary ALL. Similarly, pharmacologic knock-dow ...[more]